14 results
8-K
EX-99.1
PASG
Passage Bio Inc
13 Nov 23
Passage Bio Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights
7:00am
, as a result of our reductions in workforce.
Net Loss: Net loss was $27.1 million, or a net loss of $0.49 per basic and diluted share, for the quarter ended
8-K
PASG
Passage Bio Inc
20 Jul 23
Departure of Directors or Certain Officers
7:00am
extend its cash runway. The Company will decrease operating expenses through ongoing cash management initiatives and by reducing the workforce
8-K
EX-99.1
lnh xhavru7wkap5i
10 Nov 22
Passage Bio Reports Third Quarter 2022 Financial Results And Provides Business Updates
7:03am
8-K
EX-99.1
r2hvuvhhdg m1g
16 May 22
Passage Bio Reports First Quarter 2022 Financial Results and Provides Recent Business Highlights
7:15am
8-K
dcdae7jz
15 Mar 22
Other Events
7:10am
S-8
EX-99.1
l898j8wb4h 5ufo0z
19 Jul 21
Registration of securities for employees
8:01am
S-1/A
EX-10.3
fy72tayedvke
18 Feb 20
IPO registration (amended)
6:13am
- Prev
- 1
- Next